ArticleKidney3602026
Quantitative Assessment of Kidney Interstitial Fibrosis Using Optical Spectroscopy Mediated through a Fine Needle Probe.
Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
key pointsIntrarenal elastic-scattering spectroscopy at multiple sites accurately quantifies kidney fibrosis in a CKD rat model. Machine learning analysis predicted the histologic fibrosis grades with >98% accuracy. This method provided a rapid, objective tool for kidney evaluation at the point of care without increasing bleeding complications.
backgroundQuantitative assessment of renal fibrosis on biopsy remains a time-consuming step and is subject to interobserver variability, staining inconsistencies, and sampling errors, given the heterogeneous nature of renal fibrosis. An objective, rapid, and point-of-care evaluation method at multiple locations in the kidney is particularly needed for preimplantation donor kidney assessment, where such limitations can lead to the erroneous nonuse of approximately 20% of grafts. We investigated the accuracy of an orthogonal technique-elastic scattering spectroscopy (ESS)-and compared it against the conventional interstitial fibrosis and tubular atrophy (IFTA) scale.
methodsCKD was induced in rats via an adenine-enriched diet. A customized fine-needle ESS probe was used to acquire spectral data at predetermined intrarenal depths, followed by standard histopathologic scoring. Linear regression was initially used to correlate ESS-derived spectral features with expert-reported IFTA scores. Subsequently, both continuous and categorical random forests (RFs) were implemented to predict fibrosis severity.
resultsRF regression applied to the 300-500 nm spectral range yielded R2 values of 0.925, 0.917, and 0.838 at depths of 1.5, 3 mm (renal cortex), and 5 mm (corticomedullary junction and medulla) depths, respectively. Averaging across depths increased the R2 to 0.961. Corresponding categorical RF accuracies were 98.14%, 96.74%, and 93.49%, with an averaged overall accuracy of 98.61% following five-fold cross-validation.
conclusionsIntrarenal ESS provides a robust, depth-resolved, and quantitative estimation of fibrosis that closely parallels histologic IFTA scoring. Multidepth sampling improves predictive accuracy by minimizing local variability. ESS thus represents a promising, objective, rapid, and scalable adjunct for point-of-care kidney tissue evaluation at multiple points within the kidney without increasing risk of bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.